World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
19729
World Ranking
3382
National Ranking
1563

Raphael Clynes publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Raphael Clynes sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 141 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Raphael Clynes D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Raphael Clynes sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Raphael Clynes is affiliated with Columbia University in the United States and focuses primarily on medical research. Their work spans several subfields including oncology, radiology, nuclear medicine and imaging, immunology, genetics, and pathology and forensic medicine.

Their research topics cover a range of areas with particular attention to:

  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers
  • Biosimilars and Bioanalytical Methods
  • Immunotherapy and Immune Responses
  • Colorectal Cancer Treatments and Studies
  • Prostate Cancer Treatment and Research

Raphael Clynes has contributed to several publications in multiple journals and conference venues. The most frequent venues for their publications are:

  • Regular and Young Investigator Award Abstracts (5 publications)
  • Journal of Clinical Oncology (3 publications)
  • Blood (2 publications)
  • Journal of the American Academy of Dermatology (2 publications)
  • Blood Advances (1 publication)

Some of the recent papers authored by Raphael Clynes include:

  • "A Phase 1 Study of Plamotamab, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma: Recommended Dose Safety/Efficacy Update and Escalation Exposure-Response Analysis" (2022, Blood)
  • "Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia" (2023, Blood Advances)
  • "An open-label study evaluating the efficacy of abatacept in alopecia areata" (2020, Journal of the American Academy of Dermatology)
  • "523 Preliminary clinical experience with XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors" (2021, Regular and Young Investigator Award Abstracts)
  • "A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3)" (2022, Journal of Clinical Oncology)

Frequent co-authors who have collaborated with Raphael Clynes on multiple occasions include:

  • Jitendra Kanodia
  • Mark N. Stein
  • Ying Ding
  • Steve Kye
  • Siwen Hu-Lieskovan

Best Publications

  • Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.

    Raphael A. Clynes;Terri L. Towers;Leonard G. Presta;Jeffrey V. Ravetch

  • FcR γ chain deletion results in pleiotrophic effector cell defects

    Toshiyuki Takai;Min Li;Diana Sylvestre;Raphael Clynes

  • Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

    Luzhou Xing;Zhenpeng Dai;Ali Jabbari;Jane E Cerise

  • Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis

    Raphael Clynes;Calin Dumitru;Jeffrey V. Ravetch

  • Fc receptors are required in passive and active immunity to melanoma

    Raphael Clynes;Yoshizumi Takechi;Yoichi Moroi;Alan Houghton

  • Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II

    Bitao Liang;Craig Workman;Janine Lee;Claude Chew

  • Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors.

    Raphael Clynes;Jay S. Maizes;Rodolphe Guinamard;Masao Ono

  • DIVERGENT ROLES FOR FC RECEPTORS AND COMPLEMENT IN VIVO

    Jeffrey V. Ravetch;Raphael A. Clynes

  • Cell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells

    Amy Bergtold;Dharmesh D. Desai;Anamika Gavhane;Raphael Clynes

  • Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation

    Fayyaz S. Sutterwala;Gary J. Noel;Raphael Clynes;David M. Mosser

  • Immune complex-mediated antigen presentation induces tumor immunity

    Khadija Rafiq;Amy Bergtold;Raphael Clynes

  • Cytotoxic antibodies trigger inflammation through Fc receptors

    Raphael Clynes;Jeffrey V. Ravetch

  • Tumor immunity and autoimmunity induced by immunization with homologous DNA.

    Lawrence W. Weber;Wilbur B. Bowne;Jedd D. Wolchok;Roopa Srinivasan

  • Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci

    Regina C. Betz;Lynn Petukhova;Stephan Ripke;Stephan Ripke;Hailiang Huang;Hailiang Huang

  • Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

    Julian Mackay-Wiggan;Ali Jabbari;Nhan Nguyen;Jane E. Cerise

  • Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice

    Diana Sylvestre;Raphael Clynes;Minga Ma;Henry Warren

  • IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy

    Georgia Hatzivassiliou;Ira Miller;Jun Takizawa;Nallasivam Palanisamy

  • Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

    Ali Jabbari;Zhenpeng Dai;Luzhou Xing;Jane E. Cerise

  • Augmented HER-2-specific immunity during treatment with trastuzumab and chemotherapy

    Clare Taylor;Dawn Hershman;Nina Shah;Nicole Suciu-Foca

  • Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

    Jianda Yuan;Priti S. Hegde;Raphael Clynes;Periklis G. Foukas;Periklis G. Foukas

  • Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy.

    Paolo Antonio Ascierto;Ignacio Melero;Shailender Bhatia;Petri Bono

  • CD4+ T Cell–mediated Granulomatous Pathology in Schistosomiasis Is Downregulated by a B Cell–dependent Mechanism Requiring Fc Receptor Signaling

    Dragana Jankovic;Allen W. Cheever;Marika C. Kullberg;Thomas A. Wynn

Frequent Co-Authors

Angela M. Christiano
Angela M. Christiano Columbia University
Kevan C. Herold
Kevan C. Herold Yale University
Jeffrey V. Ravetch
Jeffrey V. Ravetch Rockefeller University
Ann Marie Schmidt
Ann Marie Schmidt New York University
Keith L. Knutson
Keith L. Knutson Mayo Clinic
Edith A. Perez
Edith A. Perez Mayo Clinic
David A. Norris
David A. Norris University of Colorado Anschutz Medical Campus
Nicole Suciu-Foca
Nicole Suciu-Foca Columbia University
Karla V. Ballman
Karla V. Ballman Cornell University
Madeleine Duvic
Madeleine Duvic The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can expand career opportunities, especially in specialized nursing roles. Programs such as the easiest online nurse practitioner programs provide accessible pathways for advancing clinical skills without compromising quality education.

Specializing further, mental health-focused options like the best online pmhnp programs offer strong clinical placement rates, ensuring hands-on experience which is vital for psychiatric nurse practitioners. Affordability is also a major consideration, with several affordable pmhnp programs available to reduce financial barriers while maintaining solid training standards.

Understanding the economic prospects post-degree is important too. The dnp salary by state data highlights how Doctor of Nursing Practice graduates can expect competitive salaries, varying by location. This information helps prospective students make informed decisions about where to study and work after completing online degrees related to Immunology and healthcare.

Best Scientists Citing Raphael Clynes

Trending Scientists

Recently Published Articles